The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
Open accessAbstract
In an inducible oncogenesis model, the miR-200 family is inhibited during CSC formation but not transformation, and inhibition of miR-200b increases CSC formation. Interestingly, miR-200b directly targets Suz12, a subunit of a polycomb repressor complex (PRC2). Loss of miR-200 during CSC formation increases Suz12 expression, Suz12 binding, H3-K27 trimethylation, and Polycomb-mediated repression of the E-cadherin gene. miR-200b expression or Suz12 depletion blocks the formation and maintenance of mammospheres, and in combination with chemotherapy suppresses tumor growth and prolongs remission in mouse xenografts. Conversely, ectopic expression of Suz12 in transformed cells is sufficient to generate CSCs. The miR-200b-Suz12-cadherin pathway is important for CSC growth and invasive ability in genetically distinct breast cancer cells, and its transcriptional signature is observed in metastatic breast tumors. The interaction between miR-200 and Suz12 is highly conserved, suggesting that it represents an ancient regulatory mechanism to control the growth and function of stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical responses have also been reported in a small number of patients with SMARCB1-mutant tumours 164 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,568
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,296
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,906
Flagged first, then by citations
1 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 400
Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal, M., Lebeau, B., & Witcher, M. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1627329 · Cited by 47
Targeting epigenetic machinery: Emerging novel allosteric inhibitors
Ye, F., Huang, J. L., Wang, H., Luo, C., & Zhao, K. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107406 · Cited by 47
Hernández-Romero, I. A., Guerra-Calderas, L., Salgado-Albarrán, M., Maldonado-Huerta, T., & Soto‐Reyes, E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01091 · Cited by 46
Integrins in mammary development
Raymond, K., Faraldo, M. M., Deugnier, M., & Glukhova, M. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.03.008 · Cited by 46
Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer
Zhang, Y., Xu, B., & Zhang, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s165156 · Cited by 44
Chang, W. H., & Lai, A. G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1880-9 · Cited by 44
Network analysis of EMT and MET micro-RNA regulation in breast cancer
Garcia, D. D., Enríquez, J. E., & Lemus, E. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13903-1 · Cited by 43
Tang, H., Song, C., Ye, F., Gao, G., Ou, X., Zhang, L., Xie, X., & Xie, X. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14681 · Cited by 43
Emerging role of G9a in cancer stemness and promises as a therapeutic target
Haebe, J. R., Bergin, C. J., Sandouka, T., & Benoit, Y. D. (2021) · Oncogenesis · doi:10.1038/s41389-021-00370-7 · Cited by 43
Garrido‐Cano, I., Adam‐Artigues, A., Lameirinhas, A., Blandez, J. F., Candela‐Noguera, V., Lluch, A. M., Bermejo, B., Sancenón, F., Cejalvo, J. M., Martínez‐Máñez, R., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c07541 · Cited by 41
The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells
Zhao, Z., Li, S., Song, E., & Liu, S. (2015) · Protein & Cell · doi:10.1007/s13238-015-0199-4 · Cited by 42
Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12
Xie, Z., Cai, L., Li, R., Zheng, J., Wu, H., Yang, X., Li, H., & Wang, Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-3340-3 · Cited by 41
Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through
Batista, L., Bourachot, B., Mateescu, B., Reyal, F., & Mechta‐Grigoriou, F. (2016) · Nature Communications · doi:10.1038/ncomms9959 · Cited by 41
MiR200 and miR302: Two Big Families Influencing Stem Cell Behavior
Balzano, F., Cruciani, S., Basoli, V., Santaniello, S., Facchin, F., Ventura, C., & Maioli, M. (2018) · Molecules · doi:10.3390/molecules23020282 · Cited by 41
SUZ12 Depletion Suppresses the Proliferation of Gastric Cancer Cells
Cui, Y., Chen, J., He, Z., & Xiao, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350095 · Cited by 40
Szczepanek, J., & Tretyn, A. (2023) · Biomolecules · doi:10.3390/biom13111590 · Cited by 43
Emerging Role of MicroRNAs in Cancer and Cancer Stem Cells
Hao, J., Zhao, S., Zhang, Y., Zhao, Z., Ye, R., Wen, J., & Li, J. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24702 · Cited by 41
Zhu, W., Shao, Y., & Peng, Y. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22612 · Cited by 39
Epigenetic Signaling of Cancer Stem Cells During Inflammation
Liu, Z., Ren, Y., Meng, L., Li, L., Beatson, R., Deng, J., Zhang, T., Liu, J., & Han, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772211 · Cited by 42
RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer
Bracken, C. P., Goodall, G. J., & Gregory, P. A. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.06.001 · Cited by 43
Biological and clinical significance of cancer stem cell plasticity
Zhu, Y., Luo, M., Brooks, M. D., Clouthier, S. G., & Wicha, M. S. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0032-3 · Cited by 39
MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.
You, J., Zhang, Y., Li, Y., Fang, N., Liu, B., Zu, L., & Zhou, Q. (2015) · Europe PMC (PubMed Central) · Cited by 39
Varès, G., Sai, S., Wang, B., Fujimori, A., Nenoi, M., & Nakajima, T. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.030 · Cited by 38
Benoit, Y. D., Guezguez, B., Boyd, A. L., & Bhatia, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2491 · Cited by 40
miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma
Zhang, H., Alshareef, A., Wu, C., Jiao, J.-W., Sorensen, P. H. B., Lai, R. L., Xu, L., & Li, E. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw079 · Cited by 38
Therapeutic Potential of the miRNA–ATM Axis in the Management of Tumor Radioresistance
Rezaeian, A.-H., Khanbabaei, H., & Călin, G. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1807 · Cited by 40
Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
Prabhu, K. S., Raza, A., Karedath, T., Raza, S. S., Fathima, H., Ahmed, E. I., Kuttikrishnan, S., Therachiyil, L., Kuliński, M., Dermime, S., et al. (2020) · Cancers · doi:10.3390/cancers12020351 · Cited by 38
Bosch, A., Bertran, S., Lu, Y., Garcia, A., Jones, A. M., Dawson, M. I., & Farias, E. (2012) · Breast Cancer Research · doi:10.1186/bcr3247 · Cited by 37
c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
Qu, Y., Yang, Q., Liu, J., Shi, B., Ji, M., Li, G., & Hou, P. (2017) · Theranostics · doi:10.7150/thno.19884 · Cited by 37
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes
Hanin, G., & Soreq, H. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00028 · Cited by 36
Gallardo, A., Molina, A., Asenjo, H. G., López-Onieva, L., Martorell‐Marugán, J., Espinosa-Martínez, M., Griñán‐Lisón, C., Álvarez-Pérez, J. C., Cara, F. E., Navarro-Marchal, S. A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02375-x · Cited by 39
Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology
Kyriazi, A. A., Papiris, E., Kitsos-Kalyvianakis, K., Sakellaris, G., & Baritaki, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186658 · Cited by 35
Antioxidants Maintain E-Cadherin Levels to Limit Drosophila Prohemocyte Differentiation
Gao, H., Wu, X., Simon, L., & Fossett, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107768 · Cited by 34
Watson, K. L. M., Jones, R. A., Bruce, A., & Moorehead, R. A. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.024 · Cited by 34
Chen, D., Huang, J., Feng, B. C., Pan, B., De, W., Wang, R., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109578 · Cited by 33
Sabarinathan, R., Wenzel, A., Novotny, P., Tang, X., Kalari, K. R., & Gorodkin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082699 · Cited by 33
SUZ 12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
Wu, Y., Hu, H., Zhang, W., Li, Z., Diao, P., Wang, D., Zhang, W., Wang, Y., Yang, J., & Cheng, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13638 · Cited by 41
MicroRNA regulation of epithelial plasticity in cancer
D’Amato, N. C., Howe, E. N., & Richer, J. K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.054 · Cited by 32
Chen, Y., Lu, L., Feng, B., Han, S., Cui, S., Chu, X., Chen, L., & Wang, R. (2017) · Oncotarget · doi:10.18632/oncotarget.16375 · Cited by 32
Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma
Xu, H., Mei, Q., Xiong, C., & Zhao, J. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9801-7 · Cited by 32
Stressed tumor cell, chemosensitized cancer
Wiemer, E. A. C. (2011) · Nature Medicine · doi:10.1038/nm.2593 · Cited by 32
Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
Huang, C.-E., Yu, C.-C., Hu, F., Chou, M. Y., & Tsai, L.-L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150914935 · Cited by 32
Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors
Notas, G., Pelekanou, V., Kampa, M., Alexakis, K., Sfakianakis, S. G., Laliotis, A., Askoxilakis, J., Tsentelierou, E., Tzardi, M. N., Tsapis, A., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.008 · Cited by 31
Deregulation of Epigenetic Mechanisms by the Hepatitis B Virus X Protein in Hepatocarcinogenesis
ANDRISANI, O. M. (2013) · Viruses · doi:10.3390/v5030858 · Cited by 31
Non-coding RNAs in Mammary Gland Development and Disease
Sandhu, G. K., Milevskiy, M. J. G., Wilson, W. V., Shewan, A. M., & Brown, M. A. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7417-8_7 · Cited by 31
Ruggieri, V., Russi, S., Zoppoli, P., Rocca, F. L., Angrisano, T., Falco, G., Calice, G., & Laurino, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050639 · Cited by 30
MicroRNAs, a Promising Target for Breast Cancer Stem Cells
Das, P. K., Siddika, M. A., Asha, S. Y., Aktar, S., Rakib, M. A., Khanam, J. A., Pillai, S., & Islam, F. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00439-5 · Cited by 30
Lee, Y.-Y., Yang, Y.-P., Huang, M.-C., Wang, M., Yen, S.-H., Huang, P., Chen, Y., Chiou, S., Lan, Y., Ma, H.-I., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x678364 · Cited by 30
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Zhang, W. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236094 · Cited by 29
MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1
Chen, Y., Peng, W., Lu, Y., Chen, J., Zhu, Y. Y., & Xi, T. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9351-6 · Cited by 29
O’Hara, S. P., Gradilone, S. A., Masyuk, T. V., Tabibian, J. H., & LaRusso, N. F. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0048-9 · Cited by 28
Kogan, A. A., Lapidus, R. G., Baer, M. R., & Rassool, F. V. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.005 · Cited by 28
miR‑767‑5p inhibits glioma proliferation and metastasis by targeting SUZ12
Zhang, J., Xu, S., Xu, J., Li, Y., Zhang, J., Zhang, J., & Lu, X. (2019) · Oncology Reports · doi:10.3892/or.2019.7156 · Cited by 28
Attema, J. L., Bert, A. G., Lim, Y., Kolesnikoff, N., Lawrence, D., Pillman, K. A., Smith, E., Drew, P. A., Khew‐Goodall, Y., Shannon, F. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075517 · Cited by 27
Yao, Y., & Li, N. (2020) · Bioscience Reports · doi:10.1042/bsr20200390 · Cited by 26
RetractedNanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Lv, L., Shi, Y., Wu, J., & Li, G. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s282110 · Cited by 26
Beltjens, F., Molly, D., Bertaut, A., Richard, C., Desmoulins, I., Loustalot, C., Charon‐Barra, C., Courcet, E., Bergeron, A., Ladoire, S., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33539 · Cited by 26
Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review)
Baek, S.-J., Ishii, H., Tamari, K., Hayashi, K., Nishida, N., Konno, M., Kawamoto, K., Koseki, J., Fukusumi, T., Hasegawa, S., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4236 · Cited by 26
Cancer Stem Cells in Breast Cancer
Takahashi, R., Takeshita, F., Fujiwara, T., Ono, M., & Ochiya, T. (2011) · Cancers · doi:10.3390/cancers3011311 · Cited by 25
Wu, S., Xie, J., Shi, H. S., & Wang, Z. (2020) · Bioscience Reports · doi:10.1042/bsr20194342 · Cited by 25
Yang, J., Wu, S.-P., Wang, W., Jin, Z.-R., Miao, X., Wu, Y., Gou, D., Liu, Q., & Yao, K. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111817 · Cited by 24
MicroRNAs are involved in the self-renewal and differentiation of cancer stem cells
Wang, Z., Du, W.-J., Piazza, G. A., & Xi, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.134 · Cited by 24
Liu, Y., Liu, Q., Jia, W., Chen, J., Wang, J., Ye, D., Guo, X., Chen, W., Li, G., Wang, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068990 · Cited by 25
Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges
Dewi, D. L., Ishii, H., Kano, Y., Nishikawa, S., Haraguchi, N., Sakai, D., Satoh, T., Doki, Y., & Mori, M. (2011) · Journal of gastroenterology · doi:10.1007/s00535-011-0442-6 · Cited by 27
MicroRNAs horizon in retinoblastoma.
Mirakholi, M., Mahmoudi, T., & Heidari, M. (2013) · PubMed · Cited by 24
Regulating the Many to Benefit the Few: Role of Weak Small RNA Targets
Jost, D., Nowojewski, A., & Levine, E. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.02.020 · Cited by 23
PRC2 loss amplifies Ras signaling in cancer
Baude, A., Lindroth, A. M., & Plass, C. (2014) · Nature Genetics · doi:10.1038/ng.3124 · Cited by 23
Ji, Z., He, L., Rotem, A., Janzer, A., Cheng, C. S., Regev, A., & Struhl, K. (2018) · Nature Communications · doi:10.1038/s41467-018-04406-2 · Cited by 20
Self-citationSaif, M. W., Rajagopal, S., Caplain, J., Grimm, E. A., Serebrennikova, O. B., Das, M., Tsichlis, P. N., & Martell, R. E. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03967-3 · Cited by 24
Self-citationmiRNAs Highlights in Stem and Cancer Cells
Martignani, E., Miretti, S., Accornero, P., & Baratta, M. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711797655371 · Cited by 21
Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy
Leal, J. A., Feliciano, A., & LLeonart, M. E. (2011) · Medicinal Research Reviews · doi:10.1002/med.20246 · Cited by 22
CHENG, Y.-X., ZHANG, Q.-F., Li, H., Pan, F., HUANG, J.-L., LI, B.-S., & Hu, M. S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4911 · Cited by 21
MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12
Zhang, J., Wu, W., Xu, S., Zhang, J., Zhang, J., Yu, Q., Jiao, Y., Wang, Y., Lu, A., You, Y., et al. (2017) · Tumor Biology · doi:10.1177/1010428317705766 · Cited by 21
Kooistra, S. M., Rudkjær, L. C. B., Lees, M. J., Steinhauer, C., Johansen, J. V., & Helin, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091034 · Cited by 21
Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine
Chetverina, D., Ломаев, Д. В., & Erokhin, M. (2020) · Acta Naturae · doi:10.32607/actanaturae.11090 · Cited by 18
Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer
Dong, G., Xu, J., Qi, Y.-R., Yuan, Z., & Zhao, W. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179574 · Cited by 21
Epigenetic control of immunoevasion in cancer stem cells
Galassi, C., Esteller, M., Vitale, I., & Galluzzi, L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.004 · Cited by 20
Cancer stem cells and autophagy: Facts and Perspectives
Hamaï, A., Codogno, P., & Mehrpour, M. (2014) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2014.2e1005 · Cited by 20
Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors
Sharma, V., Purkait, S., Takkar, S., Malgulwar, P. B., Kumar, A., Pathak, P., Suri, V. S., Sharma, M. C., Suri, A., Kale, S. S., et al. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-015-0245-1 · Cited by 19
Regulatory mechanisms of microRNAs in lung cancer stem cells
Fan, T. T., Wang, W., Zhang, B., Xu, Y., Chen, L., Pan, S., Hu, H., & Geng, Q. (2016) · SpringerPlus · doi:10.1186/s40064-016-3425-5 · Cited by 19
Polycomb repressor complex 2 function in breast cancer (Review)
Martin, C., & Moorehead, R. A. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5122 · Cited by 21
MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3
Cheng, M. L., Duan, P., Gao, Z., & Dai, M. (2020) · Oncology Reports · doi:10.3892/or.2020.7814 · Cited by 19
Targeted delivery of small noncoding RNA for glioblastoma
Yoo, J. Y., Yeh, M., Kaur, B., & Lee, T. J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.004 · Cited by 19
Ali, K., Nabeel, M., Mohsin, F., Iqtedar, M., Islam, M. F., Rasool, M. F., Hashmi, F. K., Hussain, S. A., & Saeed, H. (2024) · Medical Oncology · doi:10.1007/s12032-024-02347-z · Cited by 21
A miR Image of Stem Cells and Their Lineages
Yi, R., & Fuchs, E. V. (2012) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-387038-4.00007-0 · Cited by 17
Cho, I.-H., Jang, E. H., Hong, D., Jung, B., Park, M., & Kim, J.-H. (2015) · Oncology Reports · doi:10.3892/or.2015.4218 · Cited by 17
The Role of Breast Cancer Stem Cell-Related Biomarkers as Prognostic Factors
Ko, C. C. H., Chia, W. K., Selvarajah, G. T., Cheah, Y. K., Wong, Y. P., & Tan, G. C. (2020) · Diagnostics · doi:10.3390/diagnostics10090721 · Cited by 16
Epigenetic regulators: Polycomb-miRNA circuits in cancer
de Nigris, F. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.005 · Cited by 16
Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells
Duru, N., Gernapudi, R., Eades, G. L., Eckert, R. L., & Zhou, Q. Y. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-015-0022-1 · Cited by 16
Hu, H., Wang, Y., Li, Z., Zhu, Y., Zhang, W., Wang, D., Lin, T., Yang, J., Wang, Y., & Cheng, J. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0395-9 · Cited by 16
Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development
Hwang, G.-R., Yuen, J. G., & Ju, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041624 · Cited by 15
PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
Taghehchian, N., Maharati, A., Akhlaghipour, I., Zangouei, A. S., & Moghbeli, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03086-3 · Cited by 15
Fan, X., Chen, W., Fu, Z., Zeng, L., Yin, Y., & Yuan, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.6867 · Cited by 14
Ju, H., Zhang, L., Mao, L., Wu, Y., Liu, S., Ruan, M., Hu, J., & Ren, G. (2018) · Gene · doi:10.1016/j.gene.2018.06.064 · Cited by 14
Mallet, J., Shahbazi, R., Alsadi, N., & Matar, C. (2021) · Molecules · doi:10.3390/molecules26144330 · Cited by 14
Biomarkers to Target Heterogeneous Breast Cancer Stem Cells
Hwang‐Verslues, W. W. (2012) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s8-006 · Cited by 14
A miR‐206 regulated gene landscape enhances mammary epithelial differentiation
Wang, J., Aydoğdu, E., Mukhopadhyay, S., Helguero, L. A., & Williams, C. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28789 · Cited by 14
Gao, Y., Chen, L., Song, H., Chen, Y., Wang, R., & Feng, B. (2016) · Oncotarget · doi:10.18632/oncotarget.8376 · Cited by 13
Zhang, N., Tian, L., Miao, Z., & Guo, N. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0881-4 · Cited by 13
Simpson, K. E., Heumen, G. C.-V., Watson, K. L. M., Roth, M., Martin, C., & Moorehead, R. A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01784-4 · Cited by 14
Metadata
- Authors
- Iliopoulos, D., Lindahl-Allen, M., Polytarchou, C., Hirsch, H. A., Tsichlis, P. N., & Struhl, K.
- Affiliations
- Harvard University (US)
- Tufts Medical Center (US)
- Corresponding author
- Struhl, Kevin
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 39
- Issue
- 5
- Pages
- 761-772
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC2938080
- OpenAlex
- W2050306367
- Cited by
- 399
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 10 · 2022: 11 · 2021: 14 · 2020: 21 · 2019: 29 · 2018: 16 · 2017: 24 · 2016: 23 · 2015: 34 · 2014: 51 · 2013: 52 · 2012: 41
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- China Scholarship Council
- National Cancer Institute (R01CA107486, CA 57486, CA107486, R01CA057436)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- miR-200b, SUZ12, cancer stem cells, polycomb repressive complex 2, H3K27me3, E-cadherin, breast cancer, mammospheres, chemoresistance, metastasis, microRNA target regulation
- MeSH terms
- Animals, Breast Neoplasms, Carrier Proteins, Female, Humans, Mice, Nude, Neoplasm Proteins, Neoplasm Transplantation, Nuclear Proteins, Repressor Proteins, RNA, Neoplasm, Transcription Factors, Transplantation, Heterologous, Neoplastic Stem Cells, Cadherins, MicroRNAs, Cell Line, Tumor, Mice, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review